CL King Upgrades IDEXX Laboratories (IDXX) to Buy
CL King upgraded IDEXX Laboratories (NASDAQ: IDXX) from Neutral to Buy with a price target of $200.00.
For an analyst ratings summary and ratings history on IDEXX Laboratories click here. For more ratings news on IDEXX Laboratories click here.
Shares of IDEXX Laboratories closed at $164.40 yesterday.